Chargement en cours...
Faldaprevir for the Treatment of Hepatitis C
The current treatments for chronic hepatitis C virus (HCV) genotype 1 infection are combinations of direct-acting antivirals, and faldaprevir is one of the new generation of HCV NS3/4A protease inhibitors. At the end of 2013, the US Food and Drug Administration (FDA) approved the HCV NS3/4A protease...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394460/ https://ncbi.nlm.nih.gov/pubmed/25749475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms16034985 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|